Hoerter Steven L. 4
4 · MBX Biosciences, Inc. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Hoerter Steven L.
Director
Transactions
- Award
Stock option (right to buy)
2025-11-22+8,000→ 8,000 totalExercise: $27.08Exp: 2035-11-21→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The grant will vest in equal monthly installments over a one-year period from November 6, 2025, subject to the non-employee director's continued services to the Company.